BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5514762)

  • 21. Deterioration of renal function with demeclocycline administration.
    Oster JR; Epstein M; Ulano HB
    Curr Ther Res Clin Exp; 1976 Dec; 20(6):794-801. PubMed ID: 827425
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy.
    Lam KC; Tall AR; Goldstein GB; Mistilis SP
    Scand J Gastroenterol; 1973; 8(6):465-72. PubMed ID: 4589374
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of dopamine and metaraminol on the renal function of patients with septic shock.
    Hou LC; Li SZ; Xiong LZ; Chen SY; Chen M; Zhang XJ; Huo TT; Wang Q; Wang YL; Hu WN
    Chin Med J (Engl); 2007 Apr; 120(8):680-3. PubMed ID: 17517184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is the concept "hepatorenal syndrome" outmoded in surgery?].
    Schäfer H
    Langenbecks Arch Chir; 1970 Dec; 327(1):1056-9. PubMed ID: 5315538
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of reversible, uremia-inducing factors in chronic interstitial nephritis].
    Sterzel RB
    Dtsch Med Wochenschr; 1975 Feb; 100(6):252-4. PubMed ID: 1112247
    [No Abstract]   [Full Text] [Related]  

  • 26. The chemical composition of faeces in uraemia, as revealed by in-vivo faecal dialysis.
    Wilson DR; Ing TS; Metcalfe-Gibson A; Wrong OM
    Clin Sci; 1968 Oct; 35(2):197-209. PubMed ID: 5721228
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnosis and treatment of hyperazotemia in liver cirrhosis].
    Loginov AS; Blok IuE
    Ter Arkh; 1983; 55(9):126-31. PubMed ID: 6635969
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies of nitrogen metabolism in chronic uremia].
    Bergstron J; Fürst P; Josephson B; Noree LO
    Minerva Nefrol; 1971; 18(2):57-61. PubMed ID: 5566457
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of disease states on plasma protein binding of drugs.
    Reidenberg MM
    Med Clin North Am; 1974 Sep; 58(5):1103-9. PubMed ID: 4607741
    [No Abstract]   [Full Text] [Related]  

  • 30. [Behavior of glomerular filtrate and water sodium and potassium diuresis in ascitic liver cirrhosis during prolonged administration of cortisone drugs].
    Colucci CF; Castaldo A; De Luca FP
    Policlinico Prat; 1968 Aug; 75(34):1101-8. PubMed ID: 5736920
    [No Abstract]   [Full Text] [Related]  

  • 31. Recovery from anuria due to malignant hypertension.
    Eknoyan G; Siegel MB
    JAMA; 1971 Feb; 215(7):1122-5. PubMed ID: 5107595
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-dose dopamine infusion in cirrhosis with refractory ascites.
    Lin SM; Lee CS; Kao PF
    Int J Clin Pract; 1998; 52(8):533-6. PubMed ID: 10622049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BET 3: Peripheral metaraminol infusion in the emergency department.
    Anderson K; Chatha H
    Emerg Med J; 2017 Mar; 34(3):190-192. PubMed ID: 28232631
    [No Abstract]   [Full Text] [Related]  

  • 34. [The hepatorenal syndrome in hepatic cirrhosis: risk factors and evolution].
    Buligescu L; Costandache M; Moscaliu I; Copaci I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(4):349-55. PubMed ID: 6131518
    [No Abstract]   [Full Text] [Related]  

  • 35. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The "elevation of kaliemia-azotemia-oliguria" syndrome in ascitic cirrhosis. Mechanism and therapeutic results (failure of spirolactones)].
    VESIN P; GIBOUDEAU ; RENAULT H; CATTAN R
    Bull Mem Soc Med Hop Paris; 1960 Oct 14-21; 76():1013-21. PubMed ID: 13781051
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on doxycycline during intravenous and oral treatment with reference to renal function.
    Alestig K
    Scand J Infect Dis; 1973; 5(3):193-8. PubMed ID: 4767570
    [No Abstract]   [Full Text] [Related]  

  • 38. Improvement of nitrogen balance in a uremic patient by the addition of histidine to essential amino acid solutions given intravenously.
    Bergström J; Fürst P; Josephson B; Norée LO
    Life Sci II; 1970 Jul; 9(14):787-94. PubMed ID: 5478091
    [No Abstract]   [Full Text] [Related]  

  • 39. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of the relation of urinary excretion of potassium and sodium in ascitic cirrhosis].
    Vivien P; Gastard J; Loussouarn J; Saint-Drenant P; Cousin P
    Therapie; 1967; 22(1):177-89. PubMed ID: 6082052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.